Phospho-PPAR Gamma (ser273) Polyclonal Antibody

Huan Y, Pan X, Peng J, et al. A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice. Diabetes Obes Metab. 2019,21(11):2553-2563. doi: 10.1111/dom.13843

Zhang C, Luo X, Chen J, et al. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway. Diabetes. 2019,68(10):1902-1914. doi: 10.2337/db18-1055

Li B, Fang J, He T, et al. Resistin up-regulates LPL expression through the PPARγ-dependent PI3K/AKT signaling pathway impacting lipid accumulation in RAW264.7 macrophages. Cytokine. 2019,119:168-174. doi: 10.1016/j.cyto.2019.03.016

Liu Y, Yang D, Wei S, et al. Isolation and characterization of ovine monocyte-derived macrophages from peripheral blood. Vet Immunol Immunopathol. 2018,205:83-92. doi: 10.1016/j.vetimm.2018.11.004

Hou Y, Cao X, Hu X, et al. CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss. Genes Dis. 2018,5(3):290-299. doi: 10.1016/j.gendis.2018.05.004

Liu L, Zhou M, Lang H, et al. Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down-regulation of phosphorylation of PPARγ in 3T3-L1 cells. J Cell Mol Med. 2018,22(2):1247-1256. doi: 10.1111/jcmm.13403

Liu L, Wan J, Lang H, et al. Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats. Mol Cell Endocrinol. 2017,439:105-115. doi: 10.1016/j.mce.2016.10.028

Stechschulte LA, Ge C, Hinds TD Jr, et al. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2). J Biol Chem. 2016,291(47):24475-24486. doi: 10.1074/jbc.M116.752493

Maganti AV, Tersey SA, Syed F, et al. Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice. J Biol Chem. 2016,291(43):22524-22533.

Agrawal S, Chanley MA, Westbrook D, et al. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome. Sci Rep. 2016,6:24392. doi: 10.1038/srep24392